Active
SME

Q-Line Biotech Ltd

Q-Line Biotech Ltd IPO opened on 21 May 2026 and closed on 25 May 2026, with a price band of ₹326–₹343 per share. The IPO had a lot size of 400 shares, requiring a minimum investment of ₹2,74,400 per lot at the upper price band. The issue size was ₹214.48 crore, and the shares get listed on 29 May 2026.

Q-Line Biotech Ltd IPO Details

Listing Date

29 May 2026

Bid Price

₹326 - ₹343

Lot Size

400 Shares

Minimum Investment

₹2,74,400 / 2 Lots

Issue Size

₹214.48 Cr

Key Dates to Track

    Here are the important dates you need to know in order to participate in this IPO

tick

Offer Start Date

21st May

tick

Offer End Date

25th May

tick

Allotment Date

26th May

tick

Refund Initiation

27th May

tick

Demat Transfer

27th May

tick

Listing Date

29th May

About Q-Line Biotech Ltd IPO

Founded in 2010, Q-Line Biotech Ltd. operates in the in-vitro diagnostics (IVD) segment with activities spanning the development, manufacturing, marketing, import, and distribution of diagnostic reagents, consumables, and healthcare diagnostic equipment. The company supplies diagnostic products to hospitals, diagnostic laboratories, and medical colleges, either directly or through its distribution network. Its product portfolio includes clinical chemistry, haematology, immunodiagnostics, molecular diagnostics, and point-of-care (POC) devices along with rapid testing solutions. Over the years, the company has expanded its presence in the diagnostics sector through manufacturing operations, research and development activities, and quality control processes. According to company information, Q-Line Biotech Ltd. has been supplying diagnostic equipment and IVD products since 2013 to address varied healthcare diagnostic requirements across multiple institutions.

The company’s manufacturing operations include the production of reagents and diagnostic kits, along with the supply and manufacturing of pathology and IVD equipment. As of December 31, 2025, the company reported an annual manufacturing capacity of around 1.4 million kits across categories such as haematology, clinical chemistry, and rapid/ELISA testing, in addition to approximately 1,200 Selectra Machines. As of March 31, 2026, the manufacturing division included 126 employees and 223 third-party workers involved across research and development, supply chain functions, and production-related activities. The company states that its operations are supported by collaborations with external partners and internal teams to maintain manufacturing and operational processes within the diagnostic healthcare segment.

Q-Line Biotech Ltd Shareholding Pattern

  Pre-Issue Post-Issue
Promoter Group 92.24% 67.51%
Public Group 7.76% 32.49%

Q-Line Biotech Ltd IPO Reservation

QIB Shares Offered 11,88,000 (19%)
NII (HNI) Shares Offered 8,91,600 (14.26%)
Retail Shares Offered 20,79,200 (33.25%)
Anchor Investor Shares Offered 17,81,200 (28.48%)
Total Shares Offered 62,53,200
Total Shares With Anchor Investor 62,53,200

Q-Line Biotech Ltd IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 800 ₹2,74,400
Retail (Max) 2 800 ₹2,74,400
S HNI (Min) 3 1,200 ₹4,11,600
S HNI (Max) 7 2,800 ₹9,60,400
B HNI (MIN) 8 3,200 ₹10,97,600

Q-Line Biotech Ltd IPO Anchor Portion Size

Bid Date May 20, 2026

Q-Line Biotech Ltd IPO registrar

Purva Sharegistry (I) Pvt Ltd
Phone Number 91 22 2301 2517 / 8261
Email Id newissue@purvashare.com
Website www.purvashare.com

Q-Line Biotech Ltd IPO Lead Manager

1. Hem Securities Limited

2. Share India Capital Services Private Limited

Q-Line Biotech Ltd Financial Information

March 31, 2025 March 31, 2024 March 31, 2023
Net Worth ₹189.95 Cr ₹161.81 Cr ₹127.37 Cr
Reserves and Surplus ₹188.37 Cr ₹160.24 Cr ₹125.79 Cr
Total Borrowing ₹164.95 Cr ₹96.91 Cr ₹73.65 Cr

Q-Line Biotech Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid Subscription (Times)
Qualified Institutional Buyers (QIBs) 11,88,000 14,72,37,200 123.937
Non Institutional Investors (NIIs) 12,04,800 13,04,66,800 108.2892
Retail Individual Investors (RIIs) 20,79,200 14,85,41,600 71.4417
Total 44,72,000 42,62,45,600 95.3143

Strength of Q-Line Biotech Ltd

  • Established manufacturing capabilities with focus on R&D, Reverse Engineering and quality control.
  • Diversified product portfolio with focus on IVD industry.
  • Widespread distribution network with a presence across all four regions.
  • Long standing relationships with customers.
  • Track record of healthy financial performance.
  • Experienced Promoter and Management team.

Risks Involved

  • Any disruption, stoppage, slowdown or shutdown in the company manufacturing facilities or process or research and development activities could adversely affect its business, financial condition, cash flows and results of operations.
  • Any delay, interruption or reduction in the supply of the company raw materials, trade goods from its suppliers and manufacturers both domestic and imported, or an increase in the costs of such raw materials, trade goods may adversely impact the pricing and supply of the company products and has an adverse effect on the company business, financial condition, cash flows and results of operations.
  • The company business is dependent on the sale of its products through distributors which also include the company group entity POCT services. The loss of any of these distributors or third parties for any reason may adversely affect the marketing and distribution of its products and could negatively impact the company business, results of operations, financial conditions and cash flows.
  • The company is dependent on certain key suppliers to procure a significant portion of the company Raw material for production of reagents and for traded machines. Any denial of supplies or loss of the relationship with them could result in disruption in its operations, which could has an adverse effect on the company business, financial condition, results of operations and cash flows.
  • The company is required to obtain, maintain or renew its statutory and regulatory approvals, licenses, and registrations to operates the company business.
  • For manufacturing of its machines and reagents, the company is dependent on the agreement with the European companies, any failures to renew the agreement or entering into the agreement on the terms which is not favourable for its may impact the company business operations, financial condition and cash flows.
  • The company erstwhile associate company i.e. POCT Science House Private Limited and its promoters namely Saurabh Garg and Amita Garg has been subject to search and seizure operations by the Income-tax Department and any adverse outcome of these proceedings may adversely affect the company financial condition.
  • The company operations is concentrated in North India, and any loss of business in such region could has an adverse effect on the company business, results of operations and financial condition.
  • The Company requires a significant amount of working capital for continuing growth. Its inability to meet the company working capital requirements may adversely affect its results of operations.
  • The company is subject to risks arising from exchange rate fluctuations.
stock
Invest in IPOs with ease

Sign-in to invest with your demat account, or set up a new demat account for free

Industry Outlook of Q-Line Biotech IPO

  • India’s in-vitro diagnostics (IVD) industry is undergoing changes influenced by evolving healthcare requirements and wider access to diagnostic services.

  • Diagnostic testing continues to play an important role in identifying medical conditions and supporting treatment decisions.

  • The COVID-19 pandemic contributed to a rise in demand for IVD products, although market growth moderated as infection levels declined.

  • Despite the stabilisation in demand after the pandemic, the sector continues to witness growth due to ongoing healthcare developments.

  • Population growth and increasing life expectancy in India are contributing to higher demand for diagnostic and screening solutions.

  • Improved access to healthcare facilities across urban and semi-urban regions is supporting the expansion of the diagnostics market.

  • The increasing prevalence of chronic illnesses, including diabetes, cardiovascular conditions, and cancer, is driving the need for regular diagnostic testing.

  • Preventive healthcare awareness is increasing, leading to greater adoption of early screening and monitoring practices.

  • Changing public attitudes towards early disease detection and timely diagnosis are influencing the long-term development of the IVD industry.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Q-Line Biotech IPO.

Explore Other IPOs

  • Current IPOs
  • Upcoming IPOs
  • Closed IPOs
  • IPO Performance
  • All
  • MainBoard
  • SME
SUSAN ELECTRICALS INDIA LIMITED IPO
icon
Closing Tomorrow
SME IPO
Early Access
Bidding Period
11th Jun 2026 - 6th Jun 2026
Price Range
₹120.0 - 127.0
IPO Size
₹70,00,00,000
Bidding Period
12th Jun 2026 - 6th Jun 2026
Price Range
₹98.0 - 103.0
IPO Size
₹54,00,00,000
CLAY CRAFT INDIA LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
17th Jun 2026 - 6th Jun 2026
Price Range
₹193.0 - 203.0
IPO Size
₹1,10,00,00,000
  • All
  • MainBoard
  • SME
Diksha Polymers Limited IPO
icon
SME IPO
Early Access
Bidding Period
17th Jun 2026 - 6th Jun 2026
Price Range
₹112.0 - 112.0
IPO Size
₹17,90,00,000
Bidding Period
17th Jun 2026 - 6th Jun 2026
Price Range
₹21.0 - 23.0
IPO Size
₹88,51,00,000
Liotech Industries Limited IPO
icon
SME IPO
Early Access
Bidding Period
17th Jun 2026 - 6th Jun 2026
Price Range
₹321.0 - 321.0
IPO Size
₹36,02,00,000
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Aastha Spintex Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
AceVector Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanced SysTek Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advanta Enterprises Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Advit Jewels Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Agilus Diagnostics Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Airox Technologies Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Ajay Poly Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Allchem Lifescience Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Alpine Texworld Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
Annu Projects Limited IPO
icon
SME IPO
Early Access
Bidding Period
To Be Announced
Price Range
₹0.0 - 0.0
IPO Size
₹0
NO ACTIVE IPO HERE
  • All
  • MainBoard
  • SME
Bidding Period
10th Jun 2026 - 6th Jun 2026
Price Range
₹62.0 - 66.0
IPO Size
₹35,00,00,000
GENXAI ANALYTICS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
5th Jun 2026 - 6th Jun 2026
Price Range
₹110.0 - 116.0
IPO Size
₹54,84,00,000
HEXAGON NUTRITION LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
5th Jun 2026 - 6th Jun 2026
Price Range
₹42.0 - 45.0
IPO Size
₹1,39,00,00,000
VAHH CHEMICALS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
4th Jun 2026 - 6th Jun 2026
Price Range
₹61.0 - 61.0
IPO Size
₹13,00,00,000
UHM VACATION LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
4th Jun 2026 - 6th Jun 2026
Price Range
₹157.0 - 166.0
IPO Size
₹36,02,00,000
Bidding Period
3rd Jun 2026 - 6th Jun 2026
Price Range
₹182.0 - 192.0
IPO Size
₹6,31,00,00,000
MERRITRONIX LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
1st Jun 2026 - 6th Jun 2026
Price Range
₹141.0 - 149.0
IPO Size
₹70,00,00,000
SMR JEWELS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
26th May 2026 - 6th Jun 2026
Price Range
₹125.0 - 128.0
IPO Size
₹12,54,00,000
AUREATE TRADDE LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
29th May 2026 - 6th Jun 2026
Price Range
₹70.0 - 70.0
IPO Size
₹27,00,00,000
Bidding Period
26th May 2026 - 5th May 2026
Price Range
₹59.0 - 63.0
IPO Size
₹18,00,00,000
HARIKANTA OVERSEAS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
20th May 2026 - 5th May 2026
Price Range
₹86.0 - 91.0
IPO Size
₹24,00,00,000
YAASHVI JEWELLERS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
25th May 2026 - 5th May 2026
Price Range
₹83.0 - 83.0
IPO Size
₹44,00,00,000
M R MANIVENI FOODS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
22nd May 2026 - 5th May 2026
Price Range
₹51.0 - 52.0
IPO Size
₹27,00,00,000
QLINE BIOTECH LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
21st May 2026 - 5th May 2026
Price Range
₹326.0 - 343.0
IPO Size
₹2,14,00,00,000
AUTOFURNISH LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
21st May 2026 - 5th May 2026
Price Range
₹41.0 - 41.0
IPO Size
₹15,00,00,000
Bidding Period
21st May 2026 - 5th May 2026
Price Range
₹132.0 - 139.0
IPO Size
₹52,00,00,000
Bidding Period
20th May 2026 - 5th May 2026
Price Range
₹73.0 - 77.0
IPO Size
₹38,00,00,000
Bidding Period
19th May 2026 - 5th May 2026
Price Range
₹61.0 - 63.0
IPO Size
₹50,15,00,000
NFP SAMPOORNA FOODS LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
18th May 2026 - 5th May 2026
Price Range
₹52.0 - 55.0
IPO Size
₹25,00,00,000
RFBL FLEXI PACK LIMITED IPO
icon
SME IPO
Early Access
Bidding Period
12th May 2026 - 5th May 2026
Price Range
₹47.0 - 50.0
IPO Size
₹35,00,00,000
  • All
  • MainBoard
  • SME
GENXAI ANALYTICS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
116.00
Listing Day Close
97.40(-16.38%)
HEXAGON NUTRITION LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
45.00
Listing Day Close
50.39(11.11%)
VAHH CHEMICALS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
60.00
Listing Day Close
66.50(11.67%)
UHM VACATION LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
166.00
Listing Day Close
126.20(-24.10%)
Issue Prize
192.00
Listing Day Close
247.90(29.17%)
MERRITRONIX LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
149.00
Listing Day Close
297.25(99.33%)
SMR JEWELS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
128.00
Listing Day Close
103.05(-19.53%)
AUREATE TRADDE LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
70.00
Listing Day Close
66.50(-4.29%)
Issue Prize
63.00
Listing Day Close
60.57(-3.17%)
HARIKANTA OVERSEAS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
91.00
Listing Day Close
75.77(-16.48%)
YAASHVI JEWELLERS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
83.00
Listing Day Close
87.05(4.82%)
M R MANIVENI FOODS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
52.00
Listing Day Close
41.13(-21.15%)
QLINE BIOTECH LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
343.00
Listing Day Close
474.60(38.48%)
AUTOFURNISH LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
41.00
Listing Day Close
45.15(9.76%)
Issue Prize
139.00
Listing Day Close
115.80(-16.55%)
Issue Prize
77.00
Listing Day Close
124.00(61.04%)
Issue Prize
63.00
Listing Day Close
72.75(15.87%)
NFP SAMPOORNA FOODS LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
55.00
Listing Day Close
51.80(-5.45%)
RFBL FLEXI PACK LIMITED IPO
icon
SME IPO
Early Access
Issue Prize
50.00
Listing Day Close
55.10(10.00%)
Issue Prize
43.00
Listing Day Close
56.77(32.56%)

Frequently Asked Questions

What is Q-Line Biotech Ltd IPO?

Answer Field

Q-Line Biotech Ltd IPO is a SME IPO of 62,53,200 equity shares of a face value of ₹10 aggregating up to ₹214.48 Crores. The issue is priced at ₹326 to ₹343 per share. The minimum order quantity is 400 Shares. The IPO opens on May 21, 2026, and closes on May 25, 2026. Purva Sharegistry (I) Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Q-Line Biotech Ltd IPO will open?

Answer Field

The Q-Line Biotech Ltd IPO opens on May 21, 2026 and closes on May 25, 2026.

What is the lot size of Q-Line Biotech Ltd?

Answer Field

Q-Line Biotech Ltd lot size is 400 shares, and the minimum amount required is ₹2,74,400.

How to apply for Q-Line Biotech Ltd IPO?

Answer Field

You can apply in Q-Line Biotech Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

  • Login to Bajaj Broking account App/Website & click on IPO
  • Enter the number of lots and price at which you wish to apply.
  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
  • You will receive a mandate notification to block funds in your UPI app.
  • Approve the mandate request on your UPI and funds will be blocked.

When is Q-Line Biotech Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Q-Line Biotech Ltd IPO will be done on May 26, 2026, and the allotted shares will be credited to your demat account by May 27, 2026.

When is Q-Line Biotech Ltd IPO listing date?

Answer Field

The Q-Line Biotech Ltd listing date is May 29, 2026.

Who is the registrar of Q-Line Biotech Ltd IPO?

Answer Field

The registrar of Q-Line Biotech Ltd IPO is Purva Sharegistry (I) Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Hem Securities Limited,Share India Capital Services Private Limited will be the book-running lead manager of this IPO.

What is the fresh issue of Q-Line Biotech Ltd IPO?

Answer Field

The fresh issue size is ₹214.48 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Q-Line Biotech Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 400 shares and ₹2,74,400 amount.

How can I approve the UPI mandate request for Q-Line Biotech Ltd IPO?

Answer Field

To apply for Q-Line Biotech Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Q-Line Biotech Ltd?

Answer Field

The price of each Q-Line Biotech Ltd share will be ranging in between ₹326 to ₹343 per share.

What is the cut-off time for the UPI mandate for Q-Line Biotech Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, May 25, 2026.

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|